Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Blaise Coleman

Opioid maker Endo paid top executives $55.5 million in bonuses before bankruptcy

Days before the money-losing opioid drug firm Endo International filed for bankruptcy last week, the company paid chief executive Blaise Coleman an $11.85 million bonus.

The Philadelphia Inquirer · Aug 24, 2022

Endo, a PA opioid maker, files for bankruptcy with billions in debt

Endo International, one of the nation's larger opioid makers and with U.S. headquarters in Malvern, filed for bankruptcy protection in Manhattan on Tuesday, beset by $9.5 billion in total debt and threatened by thousands of opioid lawsuits.

The Philadelphia Inquirer · Aug 18, 2022

Endo Inks US Pact For Osteoarthritis Pain Injectable

TLC BioSciences has entered a commercialization agreement with Endo International plc (NASDAQ:ENDP) for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain. Under the agreement signed with Endo's subsidiary Endo Ventures Limited (EVL), TLC will primarily be responsible for developing the product, and EVL for obtaining regulatory…

Benzinga · Jun 13, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Endo International PLC

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.